Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01171521 · ClinicalTrials.gov registry record · NA
Management of Complex Wounds Using a Constant Tension External Tissue Expander
A NA study, sponsored by University of Missouri-Columbia.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT01171521 is a NA study that was terminated before completion, run by University of Missouri-Columbia. The registered enrollment target is 6 participants.
The verdict
NCT01171521, a NA study, was terminated before completion, sponsored by University of Missouri-Columbia.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
Complex wounds that cannot be closed primarily are at great risk for complications. A new technique utilizing external tissue expansion holds promise in rapidly decreasing wound area. Facilitation of rapid wound closure is critical in preventing wound complications. Hypothesis: Using the Dermaclose Wound Management System (Woundcare Technologies, Inc., Chanhassen, MN) in complex wounds not able to be primarily closed will decrease the time to secondary closure and decrease the need for secondary soft tissue coverage procedures, or if secondary soft tissue procedures are required, its use will decrease the size and complexity of the secondary soft tissue procedures. Null Hypothesis: The Dermaclose system will not decrease the need, dimensions, or complexity of secondary soft tissue coverage procedures in complex wounds not able to be primarily closed.
Interventions
- DEVICE DermaClose Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2010-07 |
| Est. Completion | 2015-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01171521
The ClinicalTrials.gov registry entry for NCT01171521 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DermaClose Group is the first listed.
NCT01171521 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01171521 about?
NCT01171521 is a clinical study titled "Management of Complex Wounds Using a Constant Tension External Tissue Expander". Complex wounds that cannot be closed primarily are at great risk for complications. A new technique utilizing external tissue expansion holds promise in rapidly decreasing wound area. Facilitation of rapid wound closure is critical in preventing wound complications. Hypothesis: Using the Dermaclos...
What is the current status of trial NCT01171521?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2010-07. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01171521?
The interventions under investigation include: DermaClose Group (DEVICE).
Who is sponsoring clinical trial NCT01171521?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.